Cai, Xianbin <br/><br/>
Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.  [electronic resource] 

 -  Oncology reports  Nov 2013 
 - 2449-57 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2013.2718  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminoimidazole Carboxamide--analogs & derivatives<br/>Animals<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Survival--drug effects<br/>Cyclin D1--biosynthesis<br/>Cyclin-Dependent Kinase Inhibitor p21--biosynthesis<br/>Cyclin-Dependent Kinase Inhibitor p27--biosynthesis<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Hep G2 Cells<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Metformin--pharmacology<br/>Mice<br/>Ribonucleotides--pharmacology<br/>Xenograft Model Antitumor Assays